Antibiotic therapy of diabetic foot infections: A systematic review of randomized controlled trials

@article{Tchero2018AntibioticTO,
  title={Antibiotic therapy of diabetic foot infections: A systematic review of randomized controlled trials},
  author={Huidi Tchero and Pauline Kangambega and Lazarre Noubou and Beatrice Becsangele and Sergiu Fluieraru and Luc T{\'e}ot},
  journal={Wound Repair and Regeneration},
  year={2018},
  volume={26}
}
Diabetic foot infection is a common diabetic complication that may end in lower limb amputation if not treated properly. We performed this systematic review to assess the clinical efficacy of different antibiotic regimens, whether systemic or topical, in the treatment of moderate to severe diabetic foot infections. We searched Medline, Web of Science, SCOPUS, Cochrane CENTRAL, and ScienceDirect for randomized controlled trials that evaluated the efficacy of antibiotic regimens in moderate to… 
11 Citations
Comparison of protein synthesis inhibiting antibiotics versus cell wall inhibitor antibiotics for treatment of diabetic foot.
TLDR
Protein synthesis inhibitor antibiotics have shown increased efficacy for control of infection and healing as compared to cell wall inhibitor antibiotics.
A Clinical Review of Diabetic Foot Infections.
TLDR
An evidence-based approach to clinical assessment, diagnosing osteomyelitis, as well as medical and surgical treatment is discussed, including a review of empiric and directed antibiotic treatment recommendations.
Prevalence and interrelationships of foot ulcer, risk-factors and antibiotic resistance in foot ulcers in diabetic populations: A systematic review and meta-analysis
  • M. Zubair
  • Medicine
    World journal of diabetes
  • 2020
TLDR
The gram-negative bacteria were found to be the most common reason for diabetic foot ulcers, and the role of antimicrobial resistant in its treatment was assessed.
A Retrospective Analysis of Amputation Risk Due to Diabetic Foot and Angioplasty and Free Flap Transfer to Reduce Major Amputation
TLDR
Risk factors leading to leg amputation are severe infection and reduction of arterial blood flow, and early debridement to reduce infectious inflammation and angioplasty following free flap transfer are recommended to preserve legs.
The Insights of Microbes’ Roles in Wound Healing: A Comprehensive Review
TLDR
The role of normal flora in the skin and chronic wounds is discussed and wound healing physiology is reviewed to comprehensively elucidate the role of human skin normal flora at the cellular and molecular level in a chronic injury.
Special Considerations for Diabetic Foot Reconstruction.
TLDR
To minimize the postoperative complication and days of stay in hospital, surgeons should thoroughly investigate the risk factors and underlying conditions, including the general condition and local factors.
Simultaneous HPLC determination of vildagliptin, ampicillin, sulbactam and metronidazole in pharmaceutical dosage forms and human urine
Vildagliptin is a selective, potent drug developed for the treatment of type 2 diabetes mellitus. Lower limb infections in diabetic patients are frequently caused by a mixture of aerobic and
Plasma NAP-2 levels are associated with critical limb ischemia in peripheral arterial disease patients
TLDR
Elevated plasma NAP-2 was independently associated with CLI, but it was not correlated with T2DM, and it might be an early CLI diagnostic biomarker and might provide a novel target for CLI treatment.
...
1
2
...

References

SHOWING 1-10 OF 47 REFERENCES
Systemic antibiotics for treating diabetic foot infections.
TLDR
There is evidence from one large trial at low risk of bias that patients receiving ertapenem with or without vancomycin are more likely to have resolution of their foot infection than those receiving tigecycline, but it is unclear if there is a difference in rates of clinical resolution of infection.
Diabetic foot infection: a critical review of recent randomized clinical trials on antibiotic therapy.
TLDR
Discrepancies in study design, inclusion criteria, statistical methodology, and the varying definitions of both clinical and microbiological endpoints between the published studies make it difficult to compare them, as well as to determine which regimen may be the most appropriate for patients with diabetic foot infection.
Topical versus systemic antimicrobial therapy for treating mildly infected diabetic foot ulcers: a randomized, controlled, double-blinded, multicenter trial of pexiganan cream.
TLDR
Topical pexiganan might be an effective alternative to oral antibiotic therapy in treating diabetic patients with a mildly infected foot ulcer, and might reduce the risk of selecting antimicrobial-resistant bacteria.
Antibiotics Versus Conservative Surgery for Treating Diabetic Foot Osteomyelitis: A Randomized Comparative Trial
TLDR
Antibiotic therapy and surgical treatment had similar outcomes in terms of healing rates, time to healing, and short-term complications in patients with neuropathic forefoot ulcers complicated by osteomyelitis without ischemia or necrotizing soft tissue infections.
Antibiotic therapy for diabetic foot infections: comparison of two parenteral-to-oral regimens.
TLDR
About 3 weeks of therapy with either regimen was well tolerated and effective in treating these diabetic foot infections and the overall rate of clinical cure or improvement was 85% and 83%, respectively.
The use of antibiotics in the diabetic foot.
TLDR
The proper use of antibiotics in the treatment of the diabetic foot remains contested: one view is to administer antibiotics only in the presence of clinical infection; the other is to give antibiotics freely to all patients with ulcers.
Topical application of a gentamicin-collagen sponge combined with systemic antibiotic therapy for the treatment of diabetic foot infections of moderate severity: a randomized, controlled, multicenter clinical trial.
TLDR
Topical application of the gentamicin-collagen sponge seems safe and may improve clinical and microbiological outcomes of diabetic foot infections of moderate severity when combined with standard of care.
Topical antimicrobial agents for treating foot ulcers in people with diabetes.
TLDR
The evidence on adverse events or other outcomes was uncertain, and the 95% CIs spanned benefit and harm: proportion of wounds healed RR 2.82, suggesting more wounds may heal when treated with an antimicrobial dressing than with a non-antimicrobial dressing.
Principles and practice of antibiotic therapy of diabetic foot infections
TLDR
Foot infections are a common and serious problem in diabetic patients, and in all diabetic foot infections a primary consideration is whether or not surgical intervention is required, e.g. for undrained pus, wound debridement or revascularization.
Antibiotic Treatment for Uncomplicated Neuropathic Forefoot Ulcers in Diabetes: a Controlled Trial
TLDR
There is no benefit from antibiotic treatment with amoxicillin plus clavulanic acid as a supplement to standard therapy in uncomplicated neuropathic foot ulcers, provided pressure relief is complete, and wound care is performed strictly supervised.
...
1
2
3
4
5
...